Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today announced its financial results ...

Atossa Genetics (NasdaqCM: ATOS) is a medical diagnostics company focused on the prevention of breast cancer through the development and commercialization of diagnostic tests that can detect ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Atossa Genetics Inc. (ATOS) is a stock that can certainly grab the attention of many ...

Event to feature Dr. Laura Esserman, internationally recognized surgical oncologist, breast cancer expert, and founder and ...

Discusses Challenges in Breast Cancer Drug Development and Innovation in Clinical Research May 19, 2026 4:00 PM ...

The MarketWatch News Department was not involved in the creation of this content. Recognized for Visionary Leadership and Advancing Innovative Therapies in Oncology and Healthcare Technology SEATTLE, ...

What To Know: The FDA granted one of the biopharmaceutical company’s potential treatments, (Z)-Endoxifen, a rare pediatric disease designation for the treatment of Duchenne Muscular Dystrophy. The ...

Atossa Genetics, a Seattle company that’s developing and marketing diagnostic tests for precursors to breast cancer, filed paperwork Tuesday to raise about $6 million in an initial public stock ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Atossa Genetics Inc. (ATOS) one of those stocks right now? Let ...